Collaboration enables Fusion to produce high purity actinium-225 at Company’s GMP manufacturing facility Agreement furthers BWXT Medical’s position as a global leader in medical isotope supply HAMILTON, ON and BOSTON, Nov. 16, 2023 /PRNewswire/ — Fusion Pharmaceuticals Inc. (Nasdaq:…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.